Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	May 31, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies (Details) [Line Items]
Research and development tax reimbursable percentage	43.50%	43.50%
Research and development tax incentive receivable	$ 400,881		$ 400,881			$ 433,852
Research and development expenses	$ 103,927	$ 96,560	$ 226,341	$ 122,269
Warrants to purchase (in Shares)					116,565
Exercise price (in Dollars per share)					$ 3.5938
Common shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Warrants to purchase (in Shares)	1,086,305		1,086,305
Exercise price (in Dollars per share)	$ 0.0001		$ 0.0001